Stock research
RNXT RenovoRx, Inc.
Healthcare • Biotechnology
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device...…
RenovoRx, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing therapies for solid tumor malignancies. The company's primary investigational therapy, RenovoGem, is an innovative drug and device combination. It integrates intra-arterial gemcitabine with the RenovoCath system, currently progressing through pivotal Phase III clinical trials for the treatment of locally advanced pancreatic cancer. Established in 2009, RenovoRx, Inc. maintains its headquarters in Los Altos, California.
5Y change
-85.54%
Range high
$16.02
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in RNXT?
Price
Showing 5Y history. Source: FMP historical price full.
- Prev Close
- $1.04
- Day High
- $1.10
- Day Low
- $1.04
- 52w High
- $1.45
- 52w Low
- $0.70
- Volume
- 65,088
- Avg Volume
- Beta
- 0.988
* TTM/most recent where available
Company
- Ticker
- RNXT
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Shaun R. Bagai
- Employees
- 17
- Website
- renovorx.com
Key Metrics
- Market Cap
- 39.5M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).